BRCA1 and cancer: For example, the lncRNA GUARDIN, a p53-responsive lncRNA, can maintain the expression of telomeric repeat-binding factor 2 (TRF2), sustain breast cancer 1 (BRCA1) stability and then promote cancer xenograft growth8.